XPhyto announces European Approval for 25 Minute COVID-19 PCR Test
Mar 18, 2021
CE Mark received for in vitro diagnostic (IVD) test for the detection of SARS-CoV-2Rapid results with ease of use - single 20-minute PCR cycle plus...
XPhyto Partner Receives ISO Certification for 25-Minute COVID-19 RT-PCR Test
Mar 10, 2021
Vancouver, Canada (March 10, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), and its exclusive German diagnostics development partner,...
XPhyto Places First Order For 25-Minute COVID-19 RT-PCR Tests
Feb 24, 2021
Vancouver, Canada (February 24, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), is pleased to announce that it has...
XPhyto Builds Commercial Team To Launch 25-Minute COVID-19 RT-PCR Test
Feb 22, 2021
Vancouver, Canada (February 22, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), is pleased to announce that the Company...
XPhyto European CE-IVD Application For 25-Minute COVID-19 RT-PCR Test
Feb 16, 2021
Vancouver, Canada (February 16, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), and its exclusive German diagnostics development partner,...
XPhyto Completes Successful SARS-COV-2 RT-PCR Diagnostic Test Kit Validation
Dec 17, 2020
Vancouver, Canada (December 17, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), a next-generation bioscience accelerator, and its exclusive...
XPhyto Announces RT-PCR Test For Point-Of-Care COVID-19 Detection
Oct 28, 2020
25-minute RT-PCR lab test to complement 15-minute rapid testEuropean market launch of both COVID-19 tests planned for Q1 2021 Vancouver, Canada (October 28, 2020) -...
Update On COVID-19 Rapid Test Commercialization
Sep 8, 2020
Vancouver, Canada (September 8, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), a next generation bioscience company, is pleased...
XPhyto Provides Update On COVID-19 Rapid Test
Aug 9, 2020
Vancouver, Canada (August 10, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), a next generation bioscience company, is pleased...
COVID-19 Rapid Screening Test Prototype Validation
Jul 7, 2020
Vancouver, Canada (July 6, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that its exclusive...
Infectious Disease Oral Biosensor Function Confirmed
Jun 29, 2020
Vancouver, Canada (June 29, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that its diagnostic...
Infectious Disease Oral Screening Test Advancement
Jun 15, 2020
Vancouver, Canada (June 15, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that its wholly...
